Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05768217

Community Resiliency Collective Efficacy Intervention

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of a community-centered intervention that promotes thriving and resiliency to reduce community violence.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Violence, Physical Behavior Coitus Community Violence Sexual Behavior Social Cohesion Violence in Adolescence Violence, Domestic Violence, Non-accidental Violence, Sexual Violence, Structural

Age range

13 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

This study will evaluate, via a cluster-randomized controlled trial, the effectiveness of an innovative community-centered intervention that promotes thriving and resiliency to reduce community violence. In collaboration with community partners, this study will implement a Community Resiliency Collective Efficacy Intervention (CRCEI) to engage community members in dialogue on neighborhood transformation, racial and gender equity, community leadership, and organizing for social change. Facilitating discussion and community organizing within neighborhoods about child and youth thriving is expected to increase individual and neighborhood levels of collective efficacy and reduce community violence. Using a community-partnered participatory approach, this study will use a Community Thriving Matrix tool to engage youth and adult community members in ongoing dialogue on neighborhood transformation, community leadership, and organizing for social change. This focus on envisioning and creating neighborhoods in which children and adolescents can thrive is expected to translate to increased individual and neighborhood levels of collective efficacy as well as violence reduction. Comparison neighborhoods will receive health education sessions as a control intervention. The proposed study involves diverse neighborhoods in the Pittsburgh region and collecting survey data from youth (ages 13-19 years) and adult community participants (both male and female identified). Interviews with a sub-sample of community residents and facilitators and community site leads as well as observations of intervention delivery will provide qualitative information on processes of program implementation. This study will provide the first rigorous evaluation of this community-level prevention approach.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • youth age 13 years old and up (all genders)
  • adults 18 years and older (all genders)
  • reside in neighborhoods selected to participate in the study

Exclusion criteria

  • individuals younger than 13 years old
  • individuals residing outside of participating neighborhoods

Treatment and study plan

Community Resiliency Collective Efficacy Intervention (CRCEI)

Behavioral

The Community Resiliency Collective Efficacy Intervention (CRCEI) will involve community members in dialogue on thriving, community leadership, and organizing for social change. Participants in the intervention condition will be asked to participate in 2 sessions of discussions about community thriving and a 7-week training program on the following topics: Building on the Strengths of Your Community, Collective Efficacy and its Effects on Violence Prevention & Community Mental Health, Non-threatening Peaceful Intervention Principles and Strategies: Part One, Non-threatening Peaceful Intervention Principles and Strategies: Part Two, Safety and Roles of Police and Community in Intervening, Active/Effective listening and non-violent communication skills, and Community Resources and Indirect Intervention.

Health Education Sessions

Behavioral

Comparison neighborhoods will receive health education sessions across a variety of community-identified health topics as a control intervention. (9 sessions)

Primary outcomes

  1. Change from baseline in perceptions of neighborhood collective efficacy and community cohesion

    Time frame: Change from baseline to approximately 12 months after baseline

    Composite Measure mean score (range 1 - 5; 1 is low and 5 is best) of neighborhood-level perceptions of collective efficacy and community cohesion

Secondary outcomes

  1. Community incidence of violence in 12 month period

    Time frame: Change from 1 year period before baseline to approximately 12 months after baseline

    number of incidents of violence, i.e., assaults, gun violence, referrals to child protective services, compared to control neighborhoods.

  2. Community incidence of violence in 12 month period

    Time frame: Change from 1 year period before baseline to approximately 2 years after baseline

    number of incidents of violence, i.e., assaults, gun violence, referrals to child protective services, compared to control neighborhoods.

  3. Change from baseline in collective efficacy and neighborhood social norms

    Time frame: Change from baseline to approximately 12 months after baseline

    Composite Collective Efficacy Measure mean score (range 1-5; 1 is lowest and 5 is best) of individual-level collective efficacy and neighborhood social norms

  4. Number of self-reported events of violence exposure

    Time frame: Change from baseline to approximately 12 months after baseline

    count of individual-level events of violence exposure

Study contacts

Contact information is provided by the study sponsor or research team.

Alison Culyba, MD, PhD, MPH

CONTACT

[email protected]

412-692-6056

Christi Gomez

CONTACT

[email protected]

‪(412) 969-3084‬

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Collaborators

  • Centers for Disease Control and Prevention

Registry information

Official study title

Community Resiliency Collective Efficacy Intervention (CRCEI) for Prevention of Community Violence - A Cluster Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2026
Study completion
2027
First posted
Mar 14, 2023
Registry last updated
Jul 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.